Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Letrozole|DRUG: Trastuzumab
Sponsor: Duke University
Collaborators: Genentech, Inc.|Novartis Pharmaceuticals